|
1
|
Libby P, Buring JE, Badimon L, Hansson JK,
Deanfield J, Bittencourt SM, Tokgözoğlu L and Lewis EF:
Atherosclerosis. Nat Rev Dis Primers. 5:562019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Filali-Mouncef Y, Hunter C, Roccio F,
Zagkou S, Dupont N, Primard C, Proikas-Cezanne T and Reggiori F:
The ménage à trois of autophagy, lipid droplets and liver disease.
Autophagy. 18:50–72. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chistiakov DA, Orekhov AN and Bobryshev
YV: LOX-1-Mediated effects on vascular cells in atherosclerosis.
Cell Physiol Biochem. 38:1851–1859. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Baumer Y, McCurdy S, Weatherby TM, Mehta
NN, Halbherr S, Halbherr P, Yamazaki N and Boisvert WA:
Hyperlipidemia-induced cholesterol crystal production by
endothelial cells promotes atherogenesis. Nat Commun. 8:11292017.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Giannotti KC, Weinert S, Viana MN, Leiguez
E, Araujo TLS, Laurindo FRM, Lomonte B, Braun-Dullaeus R and
Teixeira C: A secreted phospholipase A2 induces formation of smooth
muscle foam cells which transdifferentiate to Macrophage-like
state. Molecules. 24:32442019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Robichaud S, Fairman G, Vijithakumar V,
Mak E, Cook DP, Pelletier AR, Huard S, Vanderhyden BC, Figeys D,
Lavallée-Adam M, et al: Identification of novel lipid droplet
factors that regulate lipophagy and cholesterol efflux in
macrophage foam cells. Autophagy. 17:3671–3689. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Pu M, Zheng W, Zhang H, Wan W, Peng C,
Chen X, Liu X, Xu Z, Zhou T, Sun Q, et al: ORP8 acts as a lipophagy
receptor to mediate lipid droplet turnover. Protein Cell.
14:653–667. 2023.PubMed/NCBI
|
|
8
|
Chung J, Park J, Lai ZW, Lambert TJ,
Richards RC, Zhang J, Walther TC and Farese RV Jr: The Troyer
syndrome protein spartin mediates selective autophagy of lipid
droplets. Nat Cell Biol. 25:1101–1110. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jin Y, Zhang L, Huang X, Ma Y, Liu J,
Zhang H and Li X: Role of inhibition of cellular foaming by
lipophagy in atherosclerosis. Chin J Pathophysiol. 40:564–571.
2024.
|
|
10
|
Yang M, Zhang Y and Ren J: Autophagic
regulation of lipid homeostasis in cardiometabolic syndrome. Front
Cardiovasc Med. 5:382018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang S, Peng X, Yang S, Li X, Huang M,
Wei S, Liu J, He G, Zheng H, Yang L, et al: The regulation,
function, and role of lipophagy, a form of selective autophagy, in
metabolic disorders. Cell Death Dis. 13:1322022. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu K and Czaja MJ: Regulation of lipid
stores and metabolism by lipophagy. Cell Death Differ. 20:3–11.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ward C, Martinez-Lopez N, Otten EG,
Carroll B, Maetzel D, Singh R, Sarkar S and Korolchuk VI:
Autophagy, lipophagy and lysosomal lipid storage disorders. Biochim
Biophys Acta. 1861:269–284. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ouimet M, Franklin V, Mak E, Liao X, Tabas
I and Marcel YL: Autophagy regulates cholesterol efflux from
macrophage foam cells via lysosomal acid lipase. Cell Metab.
13:655–667. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Seok S, Fu T, Choi SE, Li Y, Zhu R, Kumar
S, Sun X, Yoon G, Kang Y, Zhong W, et al: Transcriptional
regulation of autophagy by an FXR-CREB axis. Nature. 108–111. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu Z, Meng X, Lu R, Meng X, Li S, Wang Y,
Liu X, Liu X and Liu J: PBX1 improves cognition and reduces
Amyloid-β pathology in APP/PS1 mice by transcriptionally activating
the CRTC2-CREB pathway. Aging Cell. 25:e703112026. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Paul S, Chatterjee A, Das K, Ray A, Basu
A, Mukhopadhyay S and Sen P: Thrombin confers chemotherapeutic
resistance by promoting transcriptional induction and
post-translational stabilization of pro-survival MCL1 in TNBC. J
Biol Chem. 301:1080252025. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zou L, Hong D, Li K and Jiang B:
Salt-inducible kinase 2 (SIK2) inhibitor ARN-3236 attenuates
bleomycin-induced pulmonary fibrosis in mice. BMC Pulm Med.
22:1402022. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wei N, Feng W, Pan M, Xu X, Zheng S and
Jin H: Curcumol ameliorates high-fat diet-induced hepatic fibrosis
via dual regulation of FXR-CREB and Rab18-mediated hepatic stellate
cell lipophagy. Biochim Biophys Acta Mol Cell Biol Lipids.
1871:1597102026. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lee JM, Wagner M, Xiao R, Kim KH, Feng D,
Lazar MA and Moore DD: Nutrient-sensing nuclear receptors
coordinate autophagy. Nature. 516:112–115. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhao T, Wu K, Hogstrand C, Xu YH, Chen GH,
Wei CC and Luo Z: Lipophagy mediated carbohydrate-induced changes
of lipid metabolism via oxidative stress, endoplasmic reticulum
(ER) stress and ChREBP/PPARγ pathways. Cell Mol Life Sci.
77:1987–2003. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen K, Yuan R, Zhang Y, Geng S and Li L:
Tollip deficiency alters atherosclerosis and steatosis by
disrupting lipophagy. J Am Heart Assoc. 6:e0040782017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Schwerbel K, Kamitz A, Krahmer N, Hallahan
N, Jähnert M, Gottmann P, Lebek S, Schallschmidt T, Arends D,
Schumacher F, et al: Immunity-related GTPase induces lipophagy to
prevent excess hepatic lipid accumulation. J Hepatol. 73:771–782.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li W, Sultana N, Siraj N, Ward LJ, Pawlik
M, Levy E, Jovinge S, Bengtsson E and Yuan XM: Autophagy
dysfunction and regulatory cystatin C in macrophage death of
atherosclerosis. J Cell Mol Med. 20:1664–1672. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sergin I, Evans TD, Zhang X, Bhattacharya
S, Stokes CJ, Song E, Ali S, Dehestani B, Holloway KB, Micevych PS,
et al: Exploiting macrophage autophagy-lysosomal biogenesis as a
therapy for atherosclerosis. Nat Commun. 8:157502017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Pi H, Wang Z, Liu M, Deng P, Yu Z, Zhou Z
and Gao F: SCD1 activation impedes foam cell formation by inducing
lipophagy in oxLDL-treated human vascular smooth muscle cells. J
Cell Mol Med. 23:5259–5269. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fu Y, Deng Y, Zhang J, Chua SL and Khoo
BL: Biofilms exacerbate atherogenesis through macrophage-induced
inflammatory responses in a fibrous plaque microsystem model. Acta
Biomater. 168:333–345. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shroff A and Nazarko TY: SQSTM1, lipid
droplets and current state of their lipophagy affairs. Autophagy.
19:720–723. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Runsala M, Kuokkanen E, Uski E, Šuštar V,
Balci MÖ, Rajala J, Paavola V and Mattila PK: The Small GTPase Rab7
regulates antigen processing in B cells in a possible interplay
with autophagy machinery. Cells. 12:25662023. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kamerkar S, Singh J, Tripathy S, Bhonsle
H, Kumar M and Mallik R: Metabolic and immune-sensitive contacts
between lipid droplets and endoplasmic reticulum reconstituted in
vitro. Proc Natl Acad Sci USA. 119:e22005131192022. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang Y, Zhao H, Li X, Wang Q, Yan M, Zhang
H, Zhao T, Zhang N, Zhang P, Peng L and Li P: Formononetin
alleviates hepatic steatosis by facilitating TFEB-mediated lysosome
biogenesis and lipophagy. J Nutr Biochem. 73:1082142019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yoo J, Jeong IK, Ahn KJ, Chung HY and
Hwang YC: Fenofibrate, a PPARα agonist, reduces hepatic fat
accumulation through the upregulation of TFEB-mediated lipophagy.
Metabolism. 120:1547982021. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sinha RA, Rajak S, Singh BK and Yen PM:
Hepatic lipid catabolism via PPARα-lysosomal crosstalk. Int J Mol
Sci. 21:23912020. View Article : Google Scholar
|
|
34
|
Kim KH, Oprescu SN, Snyder MM, Kim A, Jia
Z, Yue F and Kuang S: PRMT5 mediates FoxO1 methylation and
subcellular localization to regulate lipophagy in myogenic
progenitors. Cell Rep. 42:1133292023. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wang T, Cheng Z, Zhao R, Cheng J, Ren H,
Zhang P, Liu P, Hao Q, Zhang Q, Yu X, et al: Sirt6 enhances
macrophage lipophagy and improves lipid metabolism disorder by
regulating the Wnt1/β-catenin pathway in atherosclerosis. Lipids
Health Dis. 22:1562023. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Li M, Wang Z, Wang P, Li H and Yang L:
TFEB: A emerging regulator in lipid homeostasis for
atherosclerosis. Front Physiol. 12:6399202021. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Bao Y, Cao Y and Wu H: Research progress
on the role of lipophagy in atherosclerosis and traditional Chinese
medicine intervention. Chin J Arteriosclerosis. 30:753–763.
2022.
|
|
38
|
Blagov AV, Churov AV, Golovyuk AL, Lee AA,
Kashtalap VV, Sukhorukov VN and Orekhov AN: The role of metabolic
disorders in the development of atherosclerosis. Cell Mol Biol
(Noisy-le-Grand). 70:148–155. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Garcia-Macia M, Santos-Ledo A, Leslie J,
Paish HL, Collins AL, Scott RS, Watson A, Burgoyne RA, White S,
French J, et al: A mammalian target of Rapamycin-Perilipin 3
(mTORC1-Plin3) pathway is essential to activate lipophagy and
protects against hepatosteatosis. Hepatology. 74:3441–3459. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yano K, Yamaguchi K, Seko Y, Okishio S,
Ishiba H, Tochiki N, Takahashi A, Kataoka S, Okuda K, Liu Y, et al:
Hepatocyte-specific fibroblast growth factor 21 overexpression
ameliorates high-fat diet-induced obesity and liver steatosis in
mice. Lab Invest. 102:281–289. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zachari M and Ganley IG: The mammalian
ULK1 complex and autophagy initiation. Essays Biochem. 61:585–596.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Kim YC and Guan KL: mTOR: A pharmacologic
target for autophagy regulation. J Clin Invest. 125:25–32. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Park JM, Jung CH, Seo M, Otto NM, Grunwald
D, Kim KH, Moriarity B, Kim YM, Starker C, Nho RS, et al: The ULK1
complex mediates MTORC1 signaling to the autophagy initiation
machinery via binding and phosphorylating ATG14. Autophagy.
12:547–564. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Roczniak-Ferguson A, Petit CS, Froehlich
F, Qian S, Ky J, Angarola B, Walther TC and Ferguson SM: The
transcription factor TFEB links mTORC1 signaling to transcriptional
control of lysosome homeostasis. Sci Signal. 5:ra422012. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Gonzalez A, Hall MN, Lin SC and Hardie DG:
AMPK and TOR: The yin and yang of cellular nutrient sensing and
growth control. Cell Metab. 31:472–492. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Zhang S, Hong F, Ma C and Yang S: Hepatic
lipid metabolism disorder and atherosclerosis. Endocr Metab Immune
Disord Drug Targets. 22:590–600. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Zhang H, Xia P, Yang Z, Liu J, Zhu Y,
Huang Z, Zhang Z and Yuan Y: Cullin-associated and
neddylation-dissociated 1 regulate reprogramming of lipid
metabolism through SKP1-Cullin-1-F-boxFBXO11-mediated heterogeneous
nuclear ribonucleoprotein A2/B1 ubiquitination and promote
hepatocellular carcinoma. Clin Transl Med. 13:e14432023. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Huang Y, Yang J, Zhang J and Xiang Z: The
role and function of transcription factor EB in atherosclerosis: A
comprehensive review. Chin J Hypertension. 30:1142–1146. 2022.
|
|
49
|
Wang MY, Li EW, Gao G, Fu ZX, Zhang XW,
Wang H, Wang P, Zhang ZQ, Xu JY and Xie ZS: Zexie decoction
regulates Akt/TFEB signaling pathway to promote lipophagy in
hepatocytes. Zhongguo Zhong Yao Za Zhi. 47:6183–6190. 2022.(In
Chinese). PubMed/NCBI
|
|
50
|
Zhao X: Effects of hepatic lysosome
function on atherosclerotic mice with different lipemia. Wuhan
University; 2021
|
|
51
|
Acharya A and Demetriades C: mTORC1
activity licenses its own release from the lysosomal surface. Mol
Cell. 84:4385–4400.e7. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Xu Q, Lin R, Jiang T, Deng L, Wu Y, Yuan
Q, Qi X, Mu P, Jiang J, Deng Y and Wen J: Enhanced SIRT1-TFEB
interaction promotes lysosome biogenesis and autophagy by reducing
TFEB acetylation: Revealing the enterotoxicity disparity of
deoxynivalenol and T-2 toxin. J Agric Food Chem. 73:12993–13005.
2025. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Negoita F, Fraguas Bringas C, Hellberg K,
Luda KM, Liu H, Li Z, Cuenco J, Zhao JF, Sathe G, Ganley IG, et al:
AMPK promotes TFEB transcriptional activity through
dephosphorylation at both MTORC1-dependent and -independent sites.
Autophagy. 1–15. 2026.doi: 10.1080/15548627.2026.2629720 (Epub
ahead of print).
|
|
54
|
You Y and Liang W: SIRT1 and SIRT6: The
role in aging-related diseases. Biochim Biophys Acta Mol Basis Dis.
1869:1668152023. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Herranz D, Muñoz-Martin M, Cañamero M,
Mulero F, Martinez-Pastor B, Fernandez-Capetillo O and Serrano M:
Sirt1 improves healthy ageing and protects from metabolic
syndrome-associated cancer. Nat Commun. 1:32010. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Wang Y, Liu T, Cai Y, Liu W and Guo J:
SIRT6′s function in controlling the metabolism of lipids and
glucose in diabetic nephropathy. Front Endocrinol (Lausanne).
14:12447052023. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Wang T: Sirt6 enhances macrophage
lipophagy and improves lipid metabolism disorder to increase
atherosclerotic plaque stability. Air Force Medical University;
2020
|
|
58
|
Li B, Xin Z, Gao S, Li Y, Guo S, Fu Y, Xu
R, Wang D, Cheng J, Liu L, et al: SIRT6-regulated macrophage
efferocytosis epigenetically controls inflammation resolution of
diabetic periodontitis. Theranostics. 13:231–249. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Zi Y, Yi-An Y, Bing J, Yan L, Jing T,
Chun-Yu G, Fan P, Hao L, Jia-Ni T, Han-Jin H, et al: Sirt6-induced
autophagy restricted TREM-1-mediated pyroptosis in ox-LDL-treated
endothelial cells: Relevance to prognostication of patients with
acute myocardial infarction. Cell Death Discov. 5:882019.
View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Wang Y, Zou Y, Wang X, Liu J and Pang Y:
PLINs: Lipid droplet-associated proteins involved in lipolysis. J
Northeast Agricultural Univ. 52:82–89. 962021.
|
|
61
|
Hsieh K, Lee YK, Londos C, Raaka BM, Dalen
KT and Kimmel AR: Perilipin family members preferentially sequester
to either triacylglycerol-specific or cholesteryl-ester-specific
intracellular lipid storage droplets. J Cell Sci. 125:4067–4076.
2012.PubMed/NCBI
|
|
62
|
Lizaso A, Tan KT and Lee YH: β-adrenergic
receptor-stimulated lipolysis requires the RAB7-mediated
autolysosomal lipid degradation. Autophagy. 9:1228–1243. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Kaushik S and Cuervo AM: Degradation of
lipid droplet-associated proteins by chaperone-mediated autophagy
facilitates lipolysis. Nat Cell Biol. 17:759–770. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Cho KY, Miyoshi H, Nakamura A, Greenberg
AS and Atsumi T: Lipid droplet protein PLIN1 regulates inflammatory
polarity in human macrophages and is involved - in atherosclerotic
plaque development by promoting stable lipid storage. J Atheroscler
Thromb. 30:170–181. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Ouyang Y, Hu M, Zhang Y, Lin H, Tang W,
Peng M, He P and Ouyang X: The role of gut microbiota and its
metabolites in the development of atherosclerosis. Chemistry of
Life. 45:43–54. 2025.(In Chinese).
|
|
66
|
Tang WH, Kitai T and Hazen SL: Gut
microbiota in cardiovascular health and disease. Circ Res.
120:1183–1196. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Gu Y, Zhang Y, Li M, Huang Z, Jiang J,
Chen Y, Chen J, Jia Y, Zhang L and Zhou F: Ferulic acid ameliorates
atherosclerotic injury by modulating gut microbiota and lipid
metabolism. Front Pharmacol. 12:6213392021. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Jeong SJ, Lee MN and Oh GT: The role of
macrophage lipophagy in reverse cholesterol transport. Endocrinol
Metab (Seoul). 32:41–46. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Liu Q, Wang YM and Gu HF: Lipophagy in
atherosclerosis. Clin Chim Acta. 511:208–214. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Björkegren JLM and Lusis AJ:
Atherosclerosis: Recent developments. Cell. 185:1630–1645. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Guo X, Hou P, Zhang S, Xu Q, Zhou M, Tang
W, Jin F, Zhang B, Guo Z, Zhao X, et al: Enhancer-associated
LncRNA-ITGA2 promotes vascular remodeling through ITGA2. Circ Res.
136:1610–1628. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Bennett MR, Sinha S and Owens GK: Vascular
smooth muscle cells in atherosclerosis. Circ Res. 118:692–702.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Zeng C, Peng Z, Huang S, Xu Z, Peng Z, Wu
Z, Lei J, Zhang X, Qin J, Ye K, et al: Metal-organic
framework-based nanoplatforms for synergistic anti-atherosclerosis
therapy by regulating the PI3K/AKT/MSR1 pathway in macrophages.
Nanoscale. 17:3071–3085. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Liu F, Shan S, Li H and Li Z: Treatment of
peroxidase derived from foxtail millet bran attenuates
atherosclerosis by inhibition of CD36 and STAT3 in vitro and in
vivo. J Agric Food Chem. 68:1276–1285. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Liu F, Shan S, Li H, Shi J, Yang R and Li
Z: Millet shell polyphenols ameliorate atherosclerosis development
by suppressing foam cell formation. J Nutr Biochem. 115:1092712023.
View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Nahapetyan H, Moulis M, Grousset E,
Faccini J, Grazide MH, Mucher E, Elbaz M, Martinet W and Vindis C:
Altered mitochondrial quality control in Atg7-deficient VSMCs
promotes enhanced apoptosis and is linked to unstable
atherosclerotic plaque phenotype. Cell Death Dis. 10:1192019.
View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Ravi S, Martin LC, Krishnan M, Kumaresan
M, Manikandan B and Ramar M: Interactions between macrophage
membrane and lipid mediators during cardiovascular diseases with
the implications of scavenger receptors. Chem Phys Lipids.
258:1053622024. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Qi X, Zhang Y, Li J, Hou D and Xiang Y:
Effect of PGC-1α on proliferation, migration, and
transdifferentiation of rat vascular smooth muscle cells induced by
high glucose. J Biomed Biotechnol. 2012:7564262012. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Zhang Q, Wen XH, Tang SL, Zhao ZW and Tang
CK: Role and therapeutic potential of gelsolin in atherosclerosis.
J Mol Cell Cardiol. 178:59–67. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Gimbrone MA Jr and Garcia-Cardena G:
Endothelial cell dysfunction and the pathobiology of
atherosclerosis. Circ Res. 118:620–636. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Pu Y, Cheng CK, Zhang H, Luo JY, Wang L,
Tomlinson B and Huang Y: Molecular mechanisms and therapeutic
perspectives of peroxisome proliferator-activated receptor alpha
agonists in cardiovascular health and disease. Med Res Rev.
43:2086–2114. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Chen Z, Ouyang C, Zhang H, Gu Y, Deng Y,
Du C, Cui C, Li S, Wang W, Kong W, et al: Vascular smooth muscle
cell-derived hydrogen sulfide promotes atherosclerotic plaque
stability via TFEB (transcription factor EB)-mediated autophagy.
Autophagy. 18:2270–2287. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Goncalves I, Pan M, Singh P, Wang W, Zhao
J, Dib L, Sundius L, Persson A, Gialeli C, Fountas P, et al:
Spatial transcriptomics reveals a key role of fibroblast-like
vascular smooth muscle cells in human atherosclerotic cell
crosstalk and stability. Eur Heart J. ehaf10912026.doi:
10.1093/eurheartj/ehaf1091 (Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Zhao L, Zhao L, Liu D, Huang F, Peng Q, Lu
J, Zhou J, Zheng S and Liu X: Vascular smooth muscle cells: A
therapeutic target in atherosclerosis. Rev Cardiovasc Med.
26:282402025. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Tang HY, Chen AQ, Zhang H, Gao XF, Kong XQ
and Zhang JJ: Vascular smooth muscle cells phenotypic switching in
cardiovascular diseases. Cells. 11:40602022. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Zhang J, Chang J, Chen V, Beg MA, Huang W,
Vick L, Wang Y, Zhang H, Yttre E, Gupta A, et al: Oxidized LDL
stimulates PKM2-mediated mtROS production and phagocytosis. J Lipid
Res. 66:1008092025. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Bardin M, Pawelzik SC, Lagrange J, Mahdi
A, Arnardottir H, Regnault V, Fève B, Lacolley P, Michel JB,
Mercier N and Bäck M: The resolvin D2-GPR18 axis is expressed in
human coronary atherosclerosis and transduces atheroprotection in
apolipoprotein E deficient mice. Biochem Pharmacol. 201:1150752022.
View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Pirillo A, Norata GD and Catapano AL:
LOX-1, OxLDL, and atherosclerosis. Mediators Inflamm.
2013:1527862013. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Daub K, Seizer P, Stellos K, Krämer BF,
Bigalke B, Schaller M, Fateh-Moghadam S, Gawaz M and Lindemann S:
Oxidized LDL-activated platelets induce vascular inflammation.
Semin Thromb Hemost. 36:146–156. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Hammoutene A, Biquard L, Lasselin J,
Kheloufi M, Tanguy M, Vion AC, Mérian J, Colnot N, Loyer X, Tedgui
A, et al: A defect in endothelial autophagy occurs in patients with
non-alcoholic steatohepatitis and promotes inflammation and
fibrosis. J Hepatol. 72:528–538. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Sotler T and Sebestjen M: PCSK9 as an
atherothrombotic risk factor. Int J Mol Sci. 24:19662023.
View Article : Google Scholar : PubMed/NCBI
|
|
92
|
El Bounkari O, Zan C, Yang B, Ebert S,
Wagner J, Bugar E, Kramer N, Bourilhon P, Kontos C, Zarwel M, et
al: An atypical atherogenic chemokine that promotes advanced
atherosclerosis and hepatic lipogenesis. Nat Commun. 16:22972025.
View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Jiang L, Bai D, Yang Y, Wu Y, Chen Y, Wang
M, Wang W, Wang H, Xiong Y, Zhu S, et al: Naringenin attenuates
Ox-LDL-induced Injury in HUVECs by regulating lipophagy partly
through the SOCE pathway. Curr Pharm Des. 31:2025–2037. 2025.
View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Wang J, Peng M, Gao J and Xu G:
Atherosclerotic vascular remodeling induced by phenotypic switching
of vascular smooth muscle cell. Chin J Arteriosclerosis.
33:269–276. 2025.
|
|
95
|
Zhuang W, Yang Y, Li H and Liang J:
Research advance of Nrf2 on atherosclerosis by regulating vascular
smooth muscle cell. Zhejiang Da Xue Xue Bao Yi Xue Ban. 50:390–395.
2021.PubMed/NCBI
|
|
96
|
Boström P, Magnusson B, Svensson PA,
Wiklund O, Borén J, Carlsson LM, Ståhlman M, Olofsson SO and Hultén
LM: Hypoxia converts human macrophages into triglyceride-loaded
foam cells. Arterioscler Thromb Vasc Biol. 26:1871–1876. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Yang R, Zhu Y, Wang Y, Ma W, Wang X, Han X
and Liu N: Recent progress in autophagy and vascular calcification.
J China Pharmaceutical Univ. 49:401–406. 2018.(In Chinese).
|
|
98
|
Wang Z, Nong T and Zheng J: Biological
connotation of Disease-stage-state of hypertension in concept of
State-target differentiation and treatment from perspective of
lipophagy. Chin J Exp Tradit Med Formulae. 30:193–201. 2024.
|
|
99
|
Chen W, Jin T, Xie Y, Zhong C, Gao H,
Zhang L, Ju J, Cheng T, Li M, Wang H, et al: Berberine partially
ameliorates cardiolipotoxicity in diabetic cardiomyopathy by
modulating SIRT3-mediated lipophagy to remodel lipid droplets
homeostasis. Br J Pharmacol. 182:5038–5056. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Hou Y and Zhao Y: The mechanisms of action
and clinical application progress of autophagy activators. J Sun
Yat-Sen Univ (Med Sci). 46:371–383. 2025.
|
|
101
|
Sabers CJ, Martin MM, Brunn GJ, Williams
JM, Dumont FJ, Wiederrecht G and Abraham RT: Isolation of a protein
target of the FKBP12-rapamycin complex in mammalian cells. J Biol
Chem. 270:815–822. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Zhang Y, Li T, Pan M, Wang W, Huang W,
Yuan Y, Xie Z, Chen Y, Peng J, Li X and Meng Y: SIRT1 prevents
cigarette smoking-induced lung fibroblasts activation by regulating
mitochondrial oxidative stress and lipid metabolism. J Transl Med.
20:2222022. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Yang Y, Bai D, Jiang L, Chen Y, Wang M,
Wang W, Wang H, He Q, Bu G, Long J and Yuan D: Stilbene glycosides
alleviate atherosclerosis partly by promoting lipophagy of
dendritic cells. Int Immunopharmacol. 143:1132232024. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Cheng H, Xu B, Zhang L, Wang Y, Chen M and
Chen S: Bortezomib alleviates antibody-mediated rejection in kidney
transplantation by facilitating Atg5 expression. J Cell Mol Med.
25:10939–10949. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Widgerow AD, Casas LA, Claytor B, Zeidler
KR and Shafiq F: Topical peptide technology and the scarring
spectrum: Linking mechanistic pathways to internal scarring
(Fibrous Banding) and external scarring (Incisional) and outcomes
in postsurgical healing. Aesthet Surg J Open Forum. 8:ojaf1692026.
View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Ferri N, Ruscica M, Fazio S and Corsini A:
Correction: Ferri et al. Low-density lipoprotein
cholesterol-lowering drugs: A narrative review. J. Clin. Med.
2024.13:943J Clin Med. 13:45822024. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Beshir SA, Hussain N, Elnor AA and Said
ASA: Umbrella review on non-statin lipid-lowering therapy. J
Cardiovasc Pharmacol Ther. 26:437–452. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Shao B, Liu C, Su D and Miao C: Research
progress in the roles of macrophage autophagy in atherosclerosis
and related drugs. Prog Pharmaceutical Sci. 41:490–496. 2017.
|
|
109
|
Watanabe T, Kotani J, Murata Y, Seguchi O,
Yanase M and Nakatani T: Tissue characterization of progressive
cardiac allograft vasculopathy in patients with everolimus therapy
compared with donor-transmitted atherosclerosis assessed using
serial intravascular imaging: A case report. Transplant Proc.
46:2456–2461. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Beutner F, Brendel D, Teupser D, Sass K,
Baber R, Mueller M, Ceglarek U and Thiery J: Effect of everolimus
on pre-existing atherosclerosis in LDL-receptor deficient mice.
Atherosclerosis. 222:337–343. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Zhang Y, Wang Y, Bao C, Xu Y, Shen H, Chen
J, Yan J and Chen Y: Metformin interacts with AMPK through binding
to γ subunit. Mol Cell Biochem. 368:69–76. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Song Q, Bi L, Zhang J, Ren R and Zhao X:
Research progress in the mechanism of atorvastatin on No-reflow of
coronary artery. Herald Med. 40:641–644. 2021.
|
|
113
|
Li Y and Liu X: Metformin improves the
abnormal proliferation of vascular smooth muscle cells and
atherosclerosis in atherosclerotic mice by regulating AMPK/ERK
pathway. J Univ South China (Med Ed). 51:32–36. 2023.
|
|
114
|
Zheng S, Du Y, Ye Q, Zha K and Feng J:
Atorvastatin enhances foam cell lipophagy and promotes cholesterol
efflux through the AMP-activated protein Kinase/Mammalian target of
rapamycin pathway. J Cardiovasc Pharmacol. 77:508–518. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Zhao L, Yu H and Tian W: Research progress
of traditional Chinese medicine monomer regulating autopha of
vascular endothelial cells and interfering atherosclersi. Chin Arch
Tradit Chin Med. 39:117–120. 2021.
|
|
116
|
Liu L, Wu Q, Chen Y, Gu G, Gao R, Peng B,
Wang Y, Li A, Guo J, Xu X, et al: Updated pharmacological effects,
molecular mechanisms, and therapeutic potential of natural product
geniposide. Molecules. 27:33192022. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Zhang L, Li J, Kou Y, Shen L, Wang H, Wang
Y, Ma R, Wu T, Yang X, Gu Y and Yi L: Mechanisms and treatment of
atherosclerosis: Focus on macrophages. Front Immunol.
15:14903872024. View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Sadeghi M, Khayati S, Dehnavi S, Almahmeed
W, Sukhorukovi VN and Sahebkar A: Regulatory impact of statins on
macrophage polarization: Mechanistic and therapeutic implications.
J Pharm Pharmacol. 76:763–775. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Wiggins BS, Backes JM and Hilleman D:
Statin-associated muscle symptoms-A review: Individualizing the
approach to optimize care. Pharmacotherapy. 42:428–438. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Al-Makhamreh HK, Toubasi AA, Obaid YY and
Albustanji FH: Significance of Statin-associated muscle symptoms
and its impact on patients adherence and outcomes. J Cardiovasc
Pharmacol. 81:185–191. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Gerber T, Nunes A, Moreira BR and
Maraschin M: Yerba mate (Ilex paraguariensis A. St.-Hil.) for new
therapeutic and nutraceutical interventions: A review of patents
issued in the last 20 years (2000–2020). Phytother Res. 37:527–548.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Ran D, Hong W, Yan W and Mengdie W:
Properties and molecular mechanisms underlying geniposide-mediated
therapeutic effects in chronic inflammatory diseases. J
Ethnopharmacol. 273:1139582021. View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Lin J, Wang X, Gu M, Chen Y, Xu J, Chau
NV, Li J, Ji X, Chu Q, Qing L and Wu W: Geniposide ameliorates
atherosclerosis by restoring lipophagy via suppressing
PARP1/PI3K/AKT signaling pathway. Phytomedicine. 129:1556172024.
View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Kim HS, Montana V, Jang HJ, Parpura V and
Kim JA: Epigallocatechin gallate (EGCG) stimulates autophagy in
vascular endothelial cells: A potential role for reducing lipid
accumulation. J Biol Chem. 288:22693–22705. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Li S, Yu H and Tian W: Research progress
of effect of traditional Chinese medicine in prevention and
treatment of atherosclerosis based on signal pathway related to
inflammatory response. Chin J Exp Tradit Med Formulae. 26:180–186.
2020.
|
|
126
|
Li Y, Xue X, Yu L, Qian J, Li X, Tian M,
Yang J, Deng R, Lu C, Xiao C and Liu Y: Recombinant high-density
lipoprotein targeted delivery of celastrol to promote foam cells
lipophagy against early atherosclerosis. J Nanobiotechnology.
23:2372025. View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Zhao X, Li K, Liu Q, Jiang M and Cao Y:
Oral exposure to SiO2 nanoparticles promotes foam cell areas in
aortic sinus of ApoE-/-Mice and epigallocatechin gallate attenuates
the effects via metabolic restoration. Cardiovasc Toxicol.
25:1837–1849. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Wang L, Pan Q and Tang C: Mechanisms
underlying the Anti-atherosclerotic effects of EGCG. Curr Mol Med.
25:1327–1335. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Xing L, Zhou X, Li AH, Li HJ, He CX, Qin
W, Zhao D, Li PQ, Zhu L and Cao HL: Atheroprotective effects and
molecular mechanism of berberine. Front Mol Biosci. 8:7626732021.
View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Zheng Y, Kou J, Wang P, Ye T, Wang Z, Gao
Z, Cong L, Li M, Dong B, Yang W, et al: Berberine-induced TFEB
deacetylation by SIRT1 promotes autophagy in peritoneal
macrophages. Aging (Albany NY). 13:7096–7119. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Zhu L, Xu JJ, Li HD, Li JJ, Cheng M, Niu
XN, Jia PC, Liu JY, Huang C, Lv XW and Li J: Berberine ameliorates
abnormal lipid metabolism via the adenosine Monophosphate-activated
protein Kinase/Sirtuin 1 pathway in alcohol-related liver disease.
Lab Invest. 103:1000412023. View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Xu Y and Wan W: Acetylation in the
regulation of autophagy. Autophagy. 19:379–387. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Wang W, Li H, Shi Y, Zhou J, Khan GJ, Zhu
J, Liu F, Duan H, Li L and Zhai K: Targeted intervention of natural
medicinal active ingredients and traditional Chinese medicine on
epigenetic modification: Possible strategies for prevention and
treatment of atherosclerosis. Phytomedicine. 122:1551392024.
View Article : Google Scholar : PubMed/NCBI
|
|
134
|
Zhai K, Deng L, Wu Y, Li H, Zhou J, Shi Y,
Jia J, Wang W, Nian S, Jilany Khan G, et al: Extracellular
vesicle-derived miR-146a as a novel crosstalk mechanism for
high-fat induced atherosclerosis by targeting SMAD4. J Adv Res.
73:729–741. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
135
|
Duan H, Li H, Feng J, Zhoua J, Shi Y, Wang
L, Dong Z, Zhai K, Hu K and Wei Z: Isodon Suzhouensis extract
interferes with miRNA expression profile for prevention and
treatment of chronic obstructive pneumonia disease. Food Sci Hum
Wellness. 14:92502502025. View Article : Google Scholar
|
|
136
|
Zhi W, Liu Y, Wang X and Zhang H: Recent
advances of traditional Chinese medicine for the prevention and
treatment of atherosclerosis. J Ethnopharmacol. 301:1157492023.
View Article : Google Scholar : PubMed/NCBI
|
|
137
|
Tan M, Wang J, Chen Z and Xie X: Exploring
global research trends in Chinese medicine for atherosclerosis: A
bibliometric study 2012–2023. Front Cardiovasc Med. 11:14001302024.
View Article : Google Scholar : PubMed/NCBI
|
|
138
|
Yang L, Wang Y, Ye X, Liu Q, Qu D and Chen
Y: Traditional Chinese medicine-based drug delivery systems for
anti-tumor therapies. Chin J Nat Med. 22:1177–1192. 2024.PubMed/NCBI
|
|
139
|
Zhang YJ, He H, Sawuer G, Ma XK, Ainiwaer
Z, Wu DD, Zhang XX and An DQ: Tianxiangdan suppresses foam cell
formation by enhancing lipophagy and reduces the progression of
atherosclerosis. In Vitro Cell Dev Biol Anim. 61:298–310. 2025.
View Article : Google Scholar : PubMed/NCBI
|
|
140
|
Li Y, Pan J, Yu JJJ, Wu X, Yang G, Pan X,
Sui G, Wang M, Cheng M, Zhu S, et al: Huayu Qutan Recipe promotes
lipophagy and cholesterol efflux through the
mTORC1/TFEB/ABCA1-SCARB1 signal axis. J Cell Mol Med.
28:e182572024. View Article : Google Scholar : PubMed/NCBI
|
|
141
|
Bao Y, Zhu L, Wang Y, Liu J, Liu Z, Li Z,
Zhou A and Wu H: Gualou-Xiebai herb pair and its active ingredients
act against atherosclerosis by suppressing VSMC-derived foam cell
formation via regulating P2RY12-mediated lipophagy. Phytomedicine.
128:1553412024. View Article : Google Scholar : PubMed/NCBI
|
|
142
|
Jiang S, Li H, Zhang L, Mu W, Zhang Y,
Chen T, Wu J, Tang H, Zheng S, Liu Y, et al: Generic diagramming
platform (GDP): A comprehensive database of high-quality biomedical
graphics. Nucleic Acids Res. 53:D1670–D1676. 2025. View Article : Google Scholar : PubMed/NCBI
|
